COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
MHRA authorizes Moderna's updated COVID-19 vaccine targeting JN.1 variant. Available for NHS and private purchase in the UK. Follows WHO recommendation for JN.1 subvariants -
-
-
-
COMMUNIQUÉ DE PRESSE
FaZe Media, a GameSquare Company, Announces New Multi-Year, Multi-Million Dollar Sponsorship and Licensing Deal with G Fuel
GameSquare's FaZe Media announces multi-million-dollar partnership with G FUEL, marking one of the largest transactions in the company's history. The collaboration includes sponsorships, product launches, and in-person events -
COMMUNIQUÉ DE PRESSE
Volatus Launches Volatus Aerospace Europe AS in Norway to Accelerate Its Expansion into the Global Market
Volatus Aerospace Inc. launches European subsidiary in Norway to expand aerial solutions market in Europe and Africa. Industry consolidation expected to create commercial opportunities for advanced drone products and operations -
COMMUNIQUÉ DE PRESSE
Volatus lance Volatus Aerospace Europe AS en Norvège pour accélérer son expansion sur le marché mondial
Volatus Aerospace Inc. annonce le lancement de sa filiale européenne en Norvège pour étendre ses solutions aériennes en Europe et en Afrique. Un expert de l'aviation dirigera la nouvelle entité -
-
COMMUNIQUÉ DE PRESSE
Protagonist Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
Protagonist Therapeutics, Inc. to participate in H.C. Wainwright 26th Annual Global Investment Conference with CEO Dinesh V. Patel in fireside chat. Focus on Phase 3 clinical development of rusfertide and JNJ-2113
